FindTrial
Sign In

Effectiveness of Nalbuphine Injection for Pain Relief After Cesarean Section Under Spinal Anesthesia

Efficacy of Im Nalbuphine as Post Operative Analgesic in Patients of LSCS Operated Under Spinal Anaesthesia - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074636
Enrollment
30
Registered
2024-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: U07-

Interventions

Intervention1: nil: nil

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women aged 20-49 years undergoing lower segment cesarean section (LSCS).

Exclusion criteria

Exclusion criteria: Exclusion criteria include lack of valid informed written consent, ASA grade III and IV, presence of bleeding disorders, use of anticoagulants, history of allergy to injection paracetamol and injection nalbuphine, and infection at the site of subarachnoid block (SAB).

Design outcomes

Primary

MeasureTime frame
A single dose of IM nalbuphine more effective & superior to IM nalbuphine with paracetamol for postoperative pain managementTimepoint: 12HOURS—

Secondary

MeasureTime frame
A single dose of IM nalbuphine more effective & superior to IM nalbuphine with paracetamol for postoperative pain managementTimepoint: 12HOURS—

Countries

India

Contacts

Public ContactDasari Lakshmi Naga Sai Sivani
sivanidasari96@gmail.com9063102572

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026